News Articles Tagged: TNBC

Polyphyllin D: A Natural Saponin's Dual Mechanism Against Triple-Negative Breast Cancer

Explore the scientific findings on Polyphyllin D, a potent natural compound from Paris polyphylla, and its dual anticancer mechanisms in TNBC cells. Learn about its effects on oxidative phosphorylation and spliceosomes, supported by proteomics. NINGBO INNO PHARMCHEM CO.,LTD. as a supplier.

Decoding Polyphyllin D's Anticancer Action: A Proteomic Deep Dive

Uncover the scientific revelations from proteomic studies on Polyphyllin D's impact on triple-negative breast cancer, focusing on its dual action on oxidative phosphorylation and spliceosome pathways. Learn more about this promising natural compound. NINGBO INNO PHARMCHEM CO.,LTD. is a key provider.

Polyphyllin D: A Saponin's Impact on Oxidative Phosphorylation and Spliceosomes in TNBC

Explore the scientific revelations regarding Polyphyllin D's anticancer effects on triple-negative breast cancer, focusing on its modulation of oxidative phosphorylation and spliceosome function, supported by proteomics. NINGBO INNO PHARMCHEM CO.,LTD. is a key supplier.

The Promising Anticancer Potential of Polyphyllin D: Insights from Proteomic Studies

Discover how Polyphyllin D, a natural saponin, exhibits anticancer effects on triple-negative breast cancer cells by influencing critical cellular pathways. Insights from proteomics and NINGBO INNO PHARMCHEM CO.,LTD.'s role as a supplier.

Harnessing Proteomics: Unraveling the Anticancer Mechanisms of Polyphyllin D in TNBC

Deep dive into the proteomic findings revealing how Polyphyllin D combats triple-negative breast cancer by affecting oxidative phosphorylation and spliceosomes. Learn about its potential as a therapeutic agent. NINGBO INNO PHARMCHEM CO.,LTD. as a supplier.

Polyphyllin D: A Natural Compound's Dual Action Against Triple-Negative Breast Cancer

Explore the groundbreaking research on Polyphyllin D, a saponin from Paris polyphylla, revealing its unique anticancer mechanisms in TNBC cells through proteomics. Learn how it targets oxidative phosphorylation and spliceosomes, offering new therapeutic avenues. NINGBO INNO PHARMCHEM CO.,LTD. supports this vital research.

Ixabepilone in Triple-Negative Breast Cancer: A New Hope

Discover the significance of ixabepilone for patients with triple-negative breast cancer, examining its efficacy and potential benefits in this challenging subtype.